MAX |
MAX: Protein max |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
1.132 |
Evidence |
|
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINA3 |
IPI00550991 |
1.132 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
F11 |
F11: Coagulation factor XI precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
1.132 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.132 |
Evidence |
|
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
1.132 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
1.132 |
Evidence |
|
MEP1B |
MEP1B: Meprin A subunit beta precursor |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
1.132 |
Evidence |
|
DNAJC13 |
DNAJC13, KIAA0678, RME8: DnaJ homolog subfamily C member 13 |
RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
1.132 |
Evidence |
|
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
TNFSF15 |
TNFSF15, RP11-428F18.1-001, hCG_27396: TNF superfamily ligand TL1A |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
1.132 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
MAPK10 |
MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
1.132 |
Evidence |
|
PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
ATXN2L |
ATXN2L, A2D, A2LG, A2LP, A2RP: Ataxin-2-like protein |
1.132 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
APOE |
APOE: Apolipoprotein E precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
1.132 |
Evidence |
|
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
JAK1 |
|
1.132 |
Evidence |
|
IL6 |
IL6, IFNB2: Interleukin-6 precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
CASP8 |
CASP8, MCH5: Caspase-8 precursor |
THOC1 |
THOC1, HPR1: THO complex subunit 1 |
1.132 |
Evidence |
|
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.132 |
Evidence |
|
TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
1.132 |
Evidence |
|